Airway management and fiberoptic tracheal intubation via the laryngeal mask in a child with Marshall-Smith syndrome.
Machotta
Andreas
A
Hoeve
Hans
H
D000402:Airway Obstruction / Q000209:etiology* / Q000628:therapy*; D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000009:adverse effects; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000009:adverse effects; D005183:Failure to Thrive; D005336:Fiber Optic Technology; D005901:Glaucoma / Q000601:surgery; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000150:complications; D007442:Intubation, Intratracheal / Q000295:instrumentation* / Q000379:methods; D017214:Laryngeal Masks / Q000009:adverse effects; D008297:Male; D019767:Maxillofacial Abnormalities / Q000150:complications; D008738:Methyl Ethers / Q000008:administration & dosage / Q000009:adverse effects; D008991:Monitoring, Physiologic / Q000379:methods; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects; D035583:Rare Diseases; D000077208:Remifentanil; D000077149:Sevoflurane; D013577:Syndrome
D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D008738:Methyl Ethers; D010880:Piperidines; D000077149:Sevoflurane; D000077208:Remifentanil